SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-121727
Filing Date
2022-11-23
Accepted
2022-11-23 16:05:27
Documents
12
Period of Report
2022-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2231244d1_8k.htm   iXBRL 8-K 25176
  Complete submission text file 0001104659-22-121727.txt   197648

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idra-20221122.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20221122_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20221122_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2231244d1_8k_htm.xml XML 3611
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 221416347
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences